Home/Filings/4/0000950170-24-062850
4//SEC Filing

Wood Steven D 4

Accession 0000950170-24-062850

CIK 0001262104other

Filed

May 20, 8:00 PM ET

Accepted

May 21, 4:00 PM ET

Size

6.2 KB

Accession

0000950170-24-062850

Insider Transaction Report

Form 4
Period: 2024-05-17
Transactions
  • Award

    Common Stock

    2024-05-17$3.17/sh+3,100$9,8274,359 total
Holdings
  • Common Stock

    (indirect: See footnote)
    67,733
Footnotes (2)
  • [F1]The price reported is a weighted-average price. These shares were purchaased in multiple transactions with prices ranging from $3.10 to $3.18 per share. The reporting person undertakes to provide MEI Pharma, Inc., any security holders of MEI Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set in this Form 4.
  • [F2]The reported shares are held of record by GreenWood Builders Fund III, LP. Mr. Steven Wood is the Chief Investment Officer at GreenWood Investors LLC, who severs as investment advisor to GreenWood Builders Fund III, LP., and as such may be deemed to beneficially own the securities held by GreenWood Builders Fund III, LP. Mr Wood disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.

Documents

1 file

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeother

Related Parties

1
  • filerCIK 0002001007

Filing Metadata

Form type
4
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:00 PM ET
Size
6.2 KB